Veru Inc.
VERUNasdaqCIK 863894HealthcareFiscal year ends Sep 30
Reports and events: 295 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-0808:17 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-384430 |
| 2026-08-1008:51 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001437749-26-026664 |
| 2026-08-1007:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-341187 |
| 2026-07-0216:08 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-294507 |
| 2026-06-0408:30 ET | 8-K | 8.01 Other events | 0001437749-26-019478 |
| 2026-05-1309:09 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001437749-26-016557 |
| 2026-05-1307:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-220569 |
| 2026-03-1316:04 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-26-008216 |
| 2026-02-1110:32 ET | 10-Q | Quarterly reportPeriod 2025-12-31 | 0001437749-26-003725 |
| 2026-02-1107:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-045527 |
| 2026-01-2816:06 ET | DEF 14A | Proxy statementPeriod 2026-03-12 | 0001140361-26-002671 |
| 2025-12-1710:49 ET | 10-K | Annual reportPeriod 2025-09-30 | 0001437749-25-038089 |
| 2025-12-1707:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-321663 |
| 2025-10-3016:15 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-258565 |
| 2025-09-2608:59 ET | 8-K | 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001437749-25-029912 |
| 2025-08-2716:05 ET | 8-K | 8.01 Other events | 0001437749-25-027858 |
| 2025-08-1210:44 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001437749-25-026072 |
| 2025-08-1207:30 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-026037 |
| 2025-08-1207:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-178463 |
| 2025-07-2516:07 ET | 8-K | 5.07 Shareholder vote results | 0001437749-25-023521 |
| 2025-06-1016:17 ET | DEF 14A | Proxy statementPeriod 2025-07-25 | 0001140361-25-022074 |
| 2025-05-0811:51 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001437749-25-015330 |
| 2025-05-0807:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-115453 |
| 2025-03-1416:28 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-25-007742 |
| 2025-02-2816:05 ET | 8-K | 3.01 Delisting notice | 0001193125-25-042467 |
| 2025-02-1314:35 ET | 10-Q | Quarterly reportPeriod 2024-12-31 | 0001437749-25-003734 |
| 2025-02-1307:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-025576 |
| 2025-01-2813:14 ET | DEF 14A | Proxy statementPeriod 2025-03-13 | 0001140361-25-002147 |
| 2025-01-0316:02 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.01 Completion of an acquisition or disposition; 2.04 Item not in the standard list; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-000208 |
| 2024-12-1615:48 ET | 10-K | Annual reportPeriod 2024-09-30 | 0001437749-24-037576 |
| 2024-09-2016:11 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-222901 |
| 2024-08-3016:08 ET | 8-K | 3.01 Delisting notice | 0001193125-24-211075 |
| 2024-08-2316:05 ET | 8-K | 1.02 Termination of a material agreement | 0001193125-24-206171 |
| 2024-08-0810:45 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001437749-24-025338 |
| 2024-08-0807:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-196459 |
| 2024-08-0216:07 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-192858 |
| 2024-07-0216:14 ET | 8-K | 5.07 Shareholder vote results | 0001193125-24-174334 |
| 2024-06-2116:25 ET | 8-K | 5.07 Shareholder vote results | 0001193125-24-165716 |
| 2024-05-2216:10 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001193125-24-144951 |
| 2024-05-0813:09 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000863894-24-000011 |
| 2024-05-0807:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-133757 |
| 2024-04-2616:27 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-118157 |
| 2024-04-2507:02 ET | 8-K | 8.01 Other events | 0001193125-24-111507 |
| 2024-04-0115:42 ET | 10-Q | Quarterly reportPeriod 2023-12-31 | 0000863894-24-000008 |
| 2024-04-0115:30 ET | 10-K/A | Annual report, amendedPeriod 2023-09-30 | 0000863894-24-000006 |
| 2024-02-2818:47 ET | 8-K | 3.01 Delisting notice | 0001193125-24-048246 |
| 2024-02-1516:06 ET | 8-K | 4.02 Non-reliance on financial statements | 0001193125-24-037535 |
| 2024-02-0807:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-027504 |
| 2024-01-2616:06 ET | 8-K | 3.01 Delisting notice | 0001193125-24-016705 |
| 2024-01-2609:00 ET | DEF 14A | Proxy statementPeriod 2024-03-26 | 0001140361-24-003976 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:58 ET. Listed shows no prices and gives no investment advice.